Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Irja Lutsar

Showing results (121-130 of 137) with videos related to

Pageof 14
Sort By:
Vaccine|August 16, 2021
Prevalence of SARS-CoV-2 IgG antibodies and their association with clinical symptoms of COVID-19 in Estonia (KoroSero-EST-1 study)Piia Jõgi, Hiie Soeorg, Diana Ingerainen, et al.
Plos One|December 20, 2024
Dynamics of SARS-CoV-2 lineages in children and adults in 2021 and 2022Hiie Soeorg, Aare Abroi, Taavi Päll, et al.
The Pediatric Infectious Disease Journal|August 8, 2022
Hand Hygiene Compliance Rates in 9 Pediatric Intensive Care Units Across Europe: Results from the Reducing Antimicrobial use and Nosocomial Infections in Kids NetworkIoannis Kopsidas, Maia De Luca, Julia Bielicki, et al.
The Journal of Antimicrobial Chemotherapy|May 4, 2019
Population pharmacokinetic meta-analysis of individual data to design the first randomized efficacy trial of vancomycin in neonates and young infantsEvelyne Jacqz-Aigrain, Stéphanie Leroux, Alison H Thomson, et al.
Viruses|March 6, 2019
Low Temperature and Low UV Indexes Correlated with Peaks of Influenza Virus Activity in Northern Europe during 2010⁻2018Aleksandr Ianevski, Eva Zusinaite, Nastassia Shtaida, et al.
Journal of Crohn'S & Colitis|September 21, 2022
Paediatric Inflammatory Bowel Disease: A Multi-Stakeholder Perspective to Improve Development of Drugs for Children and AdolescentsNicholas M Croft, Lissy de Ridder, Anne M Griffiths, et al.
The Lancet. Child & Adolescent Health|November 29, 2021
Optimised versus standard dosing of vancomycin in infants with Gram-positive sepsis (NeoVanc): a multicentre, randomised, open-label, phase 2b, non-inferiority trialLouise F Hill, Michelle N Clements, Mark A Turner, et al.
The Cochrane Database of Systematic Reviews|September 28, 2025
Efficacy and safety of respiratory syncytial virus vaccinesK M Saif-Ur-Rahman, Catherine King, Seán Olann Whelan, et al.
European Journal of Pediatrics|February 14, 2014
Current management of late onset neonatal bacterial sepsis in five European countriesIrja Lutsar, Corine Chazallon, Francesca Ippolita Calò Carducci, et al.
Clinical Pharmacokinetics|June 10, 2023
Use of Machine Learning for Dosage Individualization of Vancomycin in NeonatesBo-Hao Tang, Jin-Yuan Zhang, Karel Allegaert, et al.
Pageof 14

Showing results (121-130 of 137) with videos related to

Sort By:
Pageof 14
Vaccine|August 16, 2021
Prevalence of SARS-CoV-2 IgG antibodies and their association with clinical symptoms of COVID-19 in Estonia (KoroSero-EST-1 study)Piia Jõgi, Hiie Soeorg, Diana Ingerainen, et al.
Plos One|December 20, 2024
Dynamics of SARS-CoV-2 lineages in children and adults in 2021 and 2022Hiie Soeorg, Aare Abroi, Taavi Päll, et al.
The Pediatric Infectious Disease Journal|August 8, 2022
Hand Hygiene Compliance Rates in 9 Pediatric Intensive Care Units Across Europe: Results from the Reducing Antimicrobial use and Nosocomial Infections in Kids NetworkIoannis Kopsidas, Maia De Luca, Julia Bielicki, et al.
The Journal of Antimicrobial Chemotherapy|May 4, 2019
Population pharmacokinetic meta-analysis of individual data to design the first randomized efficacy trial of vancomycin in neonates and young infantsEvelyne Jacqz-Aigrain, Stéphanie Leroux, Alison H Thomson, et al.
Viruses|March 6, 2019
Low Temperature and Low UV Indexes Correlated with Peaks of Influenza Virus Activity in Northern Europe during 2010⁻2018Aleksandr Ianevski, Eva Zusinaite, Nastassia Shtaida, et al.
Journal of Crohn'S & Colitis|September 21, 2022
Paediatric Inflammatory Bowel Disease: A Multi-Stakeholder Perspective to Improve Development of Drugs for Children and AdolescentsNicholas M Croft, Lissy de Ridder, Anne M Griffiths, et al.
The Lancet. Child & Adolescent Health|November 29, 2021
Optimised versus standard dosing of vancomycin in infants with Gram-positive sepsis (NeoVanc): a multicentre, randomised, open-label, phase 2b, non-inferiority trialLouise F Hill, Michelle N Clements, Mark A Turner, et al.
The Cochrane Database of Systematic Reviews|September 28, 2025
Efficacy and safety of respiratory syncytial virus vaccinesK M Saif-Ur-Rahman, Catherine King, Seán Olann Whelan, et al.
European Journal of Pediatrics|February 14, 2014
Current management of late onset neonatal bacterial sepsis in five European countriesIrja Lutsar, Corine Chazallon, Francesca Ippolita Calò Carducci, et al.
Clinical Pharmacokinetics|June 10, 2023
Use of Machine Learning for Dosage Individualization of Vancomycin in NeonatesBo-Hao Tang, Jin-Yuan Zhang, Karel Allegaert, et al.
Pageof 14